Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol. by Haynes, R, Baigent, C, Harden, P, Landray, M, Akyol, M, Asderakis, A, Baxter, A, Bhandari, S, Chowdhury, P, Clancy, M, Emberson, J, Gibbs, P, Hammad, A, Herrington, W, Jayne, K, Jones, G, Krishnan, N, Lay, M, Lewis, D, Macdougall, I, Nathan, C, Neuberger, J, Newstead, C, Pararajasingam, R, Puliatti, C